TITRE OF ANTIBODIES TO THE ACETYLCHOLINE RECEPTOR IN PATIENTS WITH MYASTHENIA
- Authors: Nikishov V.N1, Bogdanov E.I2, Sigal E.I3, Sigal A.M3
-
Affiliations:
- Clinical Cancer Centre
- Каzan state medical university
- Каzan state medical academy
- Issue: Vol XLIII, No 2 (2011)
- Pages: 17-20
- Section: Articles
- URL: https://journals.eco-vector.com/1027-4898/article/view/13654
- DOI: https://doi.org/10.17816/nb13654
- ID: 13654
Cite item
Full Text
Abstract
About the authors
Vladimir N Nikishov
Clinical Cancer Centre
Email: nikishov75@mail.ru
Clinical Cancer Centre
Enver I Bogdanov
Каzan state medical university
Email: enver_bogdanov@mail.ru
кафедра неврологии и реабилитации; Казанский государственный медицинский университет; Каzan state medical university
Evgeny I Sigal
Каzan state medical academy
Email: ksma@mi.ru
Каzan state medical academy
Albert M Sigal
Каzan state medical academy
Email: ksma@mi.ru
Каzan state medical academy
References
- Ветшев П.С., Зайратьянц О.В., Ипполитов И.Х., Животов В.А. Тимомы у больных генерализованной миасте-нией // Мат. II Международн. конф., посв. 40-летию профиль-ных отделений РНЦХ РАМН. - М., 2003. - С. 27-36.
- Beekman R., Kuks J.B., Oosterhuis H.J. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients // J. Neurol. - 1997. - Vol. ;244. - P. 112--118.
- Conti-Fine B.M., Protti M.P., Bellone M., Howard J.F. Myasthenia gravis: The immunology of an autoimmune disease. - Austin, 1997.
- Conti-Fine B.M., Milani M., Kaminski H.J. Myasthenia gravis: past, present and future //. J. Clin. Invest. - 2006. - Vol. 116 (11). - P. 2843--2854.
- De Baets M., Stassen M.H. The role of antibodies in myasthenia gravis // J. Neurol. Sci. - 2002. - Vol.15, suppl.202, №1-2. - P. 5-11.
- Evoli A., Minisci C., Di Schino C. et al. Thymoma in patients with MG: characteristics and long-term outcome // Neurology. - 2002. - Vol. 59, Suppl. 12. - P. 1844-1850.
- Gronseth G.S., Barohn R.J. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology //. Neurology. - 2000. - Vol. 12, suppl. 55. - P. 7-15.
- Jaretzki A. 3rd, Barohn R.J., Ernstoff R.M., et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America // Neurology. - 2000. - Vol. 55. - P. 16-20.
- Keesey J.C. Clinical evaluation and management of myasthenia gravis // Muscle Nerve. - 2004. - Vol. 29(4). - P. 484-505.
- Kondo K. Optimal therapy for thymoma // J. Med. Invest. - 2008. - Vol. 55, Suppl. 1-2. - P. 17-28.
- Maggi L., Andreetta F., Antozzi C., Baggi F. et al. Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience // J. Neuroimmunol. - 2008. - Vol. 5. - P. 237-244.
- Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages // Cancer. - 1981. - Vol. 48. - P. 2485-2492.
- Oosterhuis H.J., Limburg P.C., Hummel-Tappel E. et al. Antiacetylcholine receptor antibody in myasthenia gravis II. Clinical and serological follow-up of individual patients // J. Neurol. Sci. - 1983. - Vol. 58. - P. 371-385.
- Shimosato Y., Mukai K. Tumors of the mediastinum. - Washington, DC: The Armed Forces Institute of Pathology, 1997.
- Skeie G.O., Romi F. Paraneoplastic myasthenia gravis: immunological and clinical aspects // Eur. J. Neurol. - 2008. - Vol. 15, Suppl. 10. - P. 1029-1033.
- Somnier F.E. Clinical implementation of anti-acetylcholine receptor antibodies // J. Neurol. Neurosurg Psychiatry. - 1993. - Vol 56. - P. 496--504.